Industrial research on new DNA technology for diagnostics: next generation sequencing and Mirna (Q10109): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item) |
(Removed claim: EU contribution (P835): 433,894.2768 euro) |
||||||||||||||
| Property / EU contribution | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 433,894.2768 Euro / rank | |||||||||||||||
| Property / EU contribution: 433,894.2768 Euro / qualifier | |||||||||||||||
| |||||||||||||||
| Property / EU contribution: 433,894.2768 Euro / qualifier | |||||||||||||||
| |||||||||||||||
Revision as of 06:58, 22 September 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Industrial research on new DNA technology for diagnostics: next generation sequencing and Mirna |
Project in Czech Republic financed by DG Regio |
Statements
10,847,356.92 Czech koruna
0 references
18,868,250.0 Czech koruna
0 references
57.49 percent
0 references
1 January 2016
0 references
28 September 2019
0 references
ELISABETH PHARMACON, spol. s r.o.
0 references
49°11'55.75"N, 16°38'29.22"E
0 references
61500
0 references
Projekt se zaměřuje na výzkum v nové oblasti DNA technologií s velkým potenciálem budoucího využití v klinické praxi pro zlepšení diagnostiky civilizačních chorob. Cílem projektu je výzkum klinicky významných miRNA molekul a jejich detekce a příprava dvou prototypů souprav pro sekvenování nové generace určených pro diagnostiku cystické fibrózy a rakoviny prsu a vaječníků. Výstupem projektu budou dva prototypy, na které bude možné navázat vývoj komerčních diagnostických souprav. a. (Czech)
0 references
The project focuses on research in a new area of DNA technology with a high potential for future use in clinical practice to improve the diagnosis of civilisation diseases. The aim of the project is research from clinically meaningful Mirna molecules and their detection and preparation of two prototypes of new generation sequencing kits intended for the diagnosis of cystic fibrosis and breast and ovarian cancer. The output of the project will be two prototypes, to be followed by the development of commercial diagnostic kits. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/15_018/0004701
0 references